skip to page content

Did Bill Ackman Get Valeant (VRX) Wrong?

Adam Hewison - MarketClub

Loading the player...

There is a lot of talk today about the stock Valeant Pharmaceuticals International Inc. (NYSE:VRX) from one of its largest shareholders, Bill Ackman. You may remember Mr. Ackman from his ill-fated forays into JCPenney, Herbalife and Target. 

Today he is defending (via a conference call) one of his biggest investments in Canadian pharmaceutical company, Valeant. This stock was very instrumental in helping Mr. Ackman's Pershing Square Capital be the best-performing hedge fund last year, with a return of 40.4%. This year it's another story as this stock has tanked and Pershing has a reported paper loss of 1.5 billion dollars. Allegations of impropriety and finagling its sales and the way it does business have all contributed to Valeant's slide in the marketplace.

The reason I bring this to your attention is because sometimes as investors we get married to a position and long after our profit has dwindled, continue to justify that same position in our minds as being good ("it will come back tomorrow," "I'll give it more time," and a host of other excuses). All of the excuses are meant to justify that we're right and eventually everyone will see that. 

As successful as Mr. Ackman has been, he does have a tendency to stay with losing positions too long, in my opinion. You only have to look back at JCPenney and Herbalife to know that what I say is true. Both of those stocks turned out to be disasters for Pershing Square Capital and Mr.Ackman.

And that brings me to my next point, which is that an unemotional approach allows you to be a "lover and not a fighter." By using a program like MarketClub's Trade Triangles in a stock like Valeant, you would've made more money in a systematic fashion than Pershing Square Capital and Bill Ackman made and have now lost in this stock.

In today's video I will be looking at Valeant and showing you exactly where the Trade Triangles would have bought and sold this stock. I will also show you how much money you would've made following this simple formula. 

In addition to Valeant Pharmaceuticals International Inc. (NYSE:VRX), I will be doing my weekend round up of what the markets have done for the week and where I see some major stocks headed for the rest of the quarter.

Back to videos

Get Started With Your 30-Day MarketClub Trial Right Now

Get Started

© Copyright MarketClub™ All rights reserved | User Agreement | Do Not Sell My Personal Information

MarketClub/INO, a division of TIFIN Group LLC, is affiliated with Magnifi via common ownership. Affiliates of Magnifi will receive cash compensation for referrals of clients who open accounts with Magnifi. Due to this compensation, a conflict of interest exists since MarketClub/INO has an incentive to recommend Magnifi LLC.

Magnifi LLC does not charge advisory fees or transaction fees for non-managed accounts. Clients who elect to have Magnifi LLC manage all or a portion of their account will be charged an advisory fee. Please see Magnifi’s Form ADV for additional information about fees and charges that may apply. Magnifi LLC receives compensation from product sponsors related to recommendations. Other fees and charges may apply.

Magnifi, normally $14 per month, will be available at no additional cost to MarketClub members. Account holders must be 18 years of age and have an approved Magnifi account. Magnifi will determine qualifying account holders at its own discretion.

U.S. Government Required Disclaimer—Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41—HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

All trades, patterns, charts, systems, etc., discussed in this advertisement and the product materials are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher or INO.com. No system or methodology has ever been developed that can guarantee profits or ensure freedom from losses. No representation or implication is being made that using the MarketClub™ methodology or system will generate profits or ensure freedom from losses. The testimonials and examples used herein are exceptional results, which do not apply to the average member, and are not intended to represent or guarantee that anyone will achieve the same or similar results. Each individual's success depends on his or her background, dedication, desire, and motivation.

×

It’s not goodbye, it’s hello Magnifi!

You are now leaving a Magnifi Communities’ website and are going to a website that is not operated by Magnifi Communities. This website is operated by Magnifi LLC, an SEC registered investment adviser affiliated with Magnifi Communities.

Magnifi Communities does not endorse this website, its sponsor, or any of the policies, activities, products, or services offered on the site. We are not responsible for the content or availability of linked site.

Take Me To Magnifi